Viewing nowJanurit Tablets 100 mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

MFDS item code 201907995 · Approved 2019.11.19 · Insurance code 671807130
Improvement of blood sugar control in type 2 diabetes
This medication is an adjunct to diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone, and in cases where blood sugar control is difficult with monotherapy in patients who have not received any diabetes medication initially, it can be used in combination with Metformin. Furthermore, it can be added to therapies that include sulfonylureas, Metformin, thiazolidinediones, and insulin when blood sugar control is insufficient with those agents alone. Additionally, when blood sugar control remains difficult despite various combination therapies, this medication can be additionally administered to improve blood glucose management. It is a medication that effectively aids patients in controlling their blood sugar levels in various situations.
For monotherapy or combination therapy, the dosage is 100 mg once daily, with a maximum daily dosage of 100 mg. This medication can be taken regardless of meals. Dosage adjustments for patients with renal impairment: 1. No dosage adjustment is needed for mild renal impairment (eGFR 60–90 mL/min/1.73 m2). 2. For moderate renal impairment (eGFR 45–60 mL/min/1.73 m2), dosage adjustment is required.
This medication can cause severe allergic reactions, so if symptoms like skin rash or difficulty breathing appear within the first 3 months of administration, discontinue use immediately and consult a physician. Acute pancreatitis, a serious inflammation of the pancreas, may occur; therefore, if symptoms like abdominal pain, vomiting, or nausea arise, inform a healthcare professional immediately. It should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and it should not be administered if there is an allergy to this medication or any of its components. In patients with reduced kidney function, drug concentration may increase, requiring dosage adjustments, and regular monitoring of kidney function is important. There is a risk of hypoglycemia, so blood sugar should be frequently checked and dosage adjusted as necessary when used in conjunction with other hypoglycemic agents like insulin or sulfonylureas. This medication may cause side effects such as upper respiratory infections, headaches, nasopharyngitis, diarrhea, and abdominal pain, so consult a physician if symptoms persist or worsen. If severe joint pain or skin blisters occur, discontinue medication immediately and seek specialist care. Women who are pregnant or breastfeeding are advised not to use this medication, and safety in children and adolescents under 18 has not been established. Elderly patients may experience decreased kidney function, so a kidney function test is recommended prior to administration and careful monitoring during treatment is necessary. In case of overdose, routine emergency measures should be taken, and some of the drug may be removed by hemodialysis if necessary. This medication has a low potential for interactions with other drugs; however, monitoring by healthcare professionals is needed when used with cyclosporine or digoxin.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a sealed container that is air-tight, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage helps to maintain the drug's effectiveness for a longer period.
Pale orange, round, biconvex film-coated tablet
30 tablets - 10 tablets/PTP[x3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.